Literature DB >> 23988024

Antibodies to the N-methyl-D-aspartate receptor and other synaptic proteins in psychosis.

Julia Deakin1, Belinda R Lennox2, Michael S Zandi3.   

Abstract

This review concentrates on the evidence for autoantibodies to cell surface synaptic proteins in psychosis and schizophrenia. We and others have recently found antibodies to the N-methyl-D-aspartate receptor in first-episode psychosis. We describe the evidence for pathogenicity and disease-relevance of these antibodies, which builds on the novel field in neuroimmunology of cell surface antibody-associated central nervous system disorders. Relevant autoantibodies in psychosis and schizophrenia are likely to be those directed to cell surface proteins, in which the likelihood of pathogenicity is greater. We discuss the evidence for this from the field of paraneoplastic neurologic syndromes and the discovery of novel cell surface antigen central nervous system autoimmune syndromes.
Copyright © 2014 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoantibody; N-methyl-D-aspartate receptor (NMDAR); encephalitis; encephalopathy; leucine-rich glioma-inactivated 1 (Lgi1); paraneoplastic; psychosis; schizophrenia; voltage-gated potassium channel complex (VGKC)

Mesh:

Substances:

Year:  2013        PMID: 23988024     DOI: 10.1016/j.biopsych.2013.07.018

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  31 in total

1.  GWAS, cytomegalovirus infection, and schizophrenia.

Authors:  Jakob Grove; Anders D Børglum; Brad D Pearce
Journal:  Curr Behav Neurosci Rep       Date:  2014-12-01

Review 2.  The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

Authors:  Emily G Severance; Dag Tveiten; Lief H Lindström; Robert H Yolken; Karl L Reichelt
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 3.  Recent advances in the neuroimmunology of cell-surface CNS autoantibody syndromes, Alzheimer's disease, traumatic brain injury and schizophrenia.

Authors:  Ed Needham; Michael S Zandi
Journal:  J Neurol       Date:  2014-09-03       Impact factor: 4.849

4.  Autoimmune Encephalitis in Postpartum Psychosis.

Authors:  Veerle Bergink; Thaís Armangue; Maarten J Titulaer; Sander Markx; Josep Dalmau; Steven A Kushner
Journal:  Am J Psychiatry       Date:  2015-07-17       Impact factor: 18.112

Review 5.  Ketamine and phencyclidine: the good, the bad and the unexpected.

Authors:  D Lodge; M S Mercier
Journal:  Br J Pharmacol       Date:  2015-07-28       Impact factor: 8.739

Review 6.  [Update on anti-N-methyl-D-aspartate receptor encephalitis].

Authors:  S Kovac; J Alferink; D Ahmetspahic; V Arolt; N Melzer
Journal:  Nervenarzt       Date:  2018-01       Impact factor: 1.214

7.  Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.

Authors:  Nuria Gresa-Arribas; Maarten J Titulaer; Abiguei Torrents; Esther Aguilar; Lindsey McCracken; Frank Leypoldt; Amy J Gleichman; Rita Balice-Gordon; Myrna R Rosenfeld; David Lynch; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-12-18       Impact factor: 44.182

8.  Brain free water alterations in first-episode psychosis: a longitudinal analysis of diagnosis, course of illness, and medication effects.

Authors:  J Y Guo; T A Lesh; T A Niendam; J D Ragland; L M Tully; C S Carter
Journal:  Psychol Med       Date:  2020-01-08       Impact factor: 7.723

Review 9.  Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment.

Authors:  Golam M Khandaker; Lesley Cousins; Julia Deakin; Belinda R Lennox; Robert Yolken; Peter B Jones
Journal:  Lancet Psychiatry       Date:  2015-02-25       Impact factor: 27.083

10.  Progressive cortical and sub-cortical alterations in patients with anti-N-methyl-D-aspartate receptor encephalitis.

Authors:  Jinping Xu; Yuanyuan Guo; Jiaying Li; Xinyi Lv; Juanjuan Zhang; Jinhuan Zhang; Qingmao Hu; Kai Wang; Yanghua Tian
Journal:  J Neurol       Date:  2021-07-23       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.